A study identified an accurate approach to measuring disease activity in patients with systemic lupus erythematosus (SLE), which is crucial for clinical management.

Objective Evaluation of the Medical Mediation Foundation’s Conflict Management Programme (CMP)—a structured process for ...

Wind and solar power have grown faster than almost anyone predicted, but projecting their future expansion remains ...

Autism Spectrum Disorder now affects approximately 1 in 31 children in the United States, according to the CDC’s 2025 ADDM ...

The Schwab U.S. Dividend Equity ETF (SCHD) has criteria that ensure it contains high-quality companies. The Vanguard Dividend Appreciation ETF (VIG) holds more tech stocks than most typical dividend ...

Exotics in The Division 2 can make or break a build, depending on how players implement them with other gears. These special gear pieces come with complicated perks that can alter a player's game ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." The 2-2-2 method was created by Ian K. Smith, MD, author of The Met Flex Diet: Burn Better Fuel, Burn ...

ETFs offer a convenient way for investors to gain broad, diversified exposure to stocks. It's hard to beat Vanguard's S&P 500 ETF, which has delivered excellent results over time. Vanguard's ...

The Northrop B-2 Spirit is one of the United States Air Force's most well-known and fascinating aircraft. The heavy strategic bomber can fly to and drop ordnance on targets anywhere in the world, and ...

Derek's love of games came at an early age when his parents first brought home the Nintendo Entertainment System. From then on, countless nights were spent hunting ducks, stomping turtles, exploring ...

While we may have gotten away with high-volume, high-intensity training and minimal recovery in our twenties, we lose some of that flexibility as time goes on. Gone are the days when we could down a ...

(RTTNews) - Biotechnology company Q32 Bio, Inc. (QTTB) announced Monday it has sold its Phase 2 complement inhibitor, ADX-097, to Akebia Therapeutics, Inc. (AKBA). ADX-097, the lead product candidate ...